3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
1
Hypoxia
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cytarabine
3
Cyclophosphamide
3
pembrolizumab
2
fludarabine
2
Idarubicin
2
Etoposide
2
venetoclax
1
ioversol
1
interferon gamma-1b
1
fludarabine phosphate
1
fluarix
1
dubermatinib
1
daratumumab
1
asparaginase erwinia chrysanthemi recombinant
1
alovudine
1
Whole-Body Irradiation
1
Transplantation
1
Sodium Bicarbonate
1
Sirolimus
1
Photography
1
Pemetrexed
1
Mycophenolic Acid
1
Mesenchymal Stem Cell Transplantation
1
Magnetic Resonance Spectroscopy
1
Injections
1
Influenza Vaccines
1
Immunotherapy, Adoptive
1
Immune Checkpoint Inhibitors
1
Hyperbaric Oxygenation
1
Gemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Leukemia, Myeloid, Acute
×
Atovaquone
×
Clear all
NCT03568994
2026-01-27
ATACC AML
Baylor College of Medicine
Phase EARLY_PHASE1
Completed
26 enrolled